一个巨大的阿米巴肝的病例,在治疗后持续数年
Rei Yasukochi1, Hitoshi Kawasuji1, Masayoshi Ezaki1
1Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
概括
本案例研究描述了一种罕见的巨型阿米巴肝 (ALA),尽管得到了适当的治疗,但仍持续了多年. 它强调在严重,快速进展的ALA病例中要谨慎.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 寄生虫学的寄生虫学
背景情况:
- 肝 (ALA) 是一种常见的肝脏感染,由Entamoeba histolytica引起.
- 巨型肝很少见,可能会出现严重的并发症.
研究的目的:
- 报告一个独特的巨型阿米巴肝的病例,尽管接受了治疗,但其大小仍然持久.
- 要突出管理严重的 ALA 与 fulminant 进展的挑战.
主要方法:
- 一名64岁的男性患者患有巨型肝,接受了抗生素 (美特罗尼达,美罗,达普托米辛) 和皮肤通排水的治疗.
- 在排水液中通过PCR识别了Entamoeba histolytica.
- 用计算机断层扫描 (CT) 进行了长期随访.
主要成果:
- 患者出现严重的呼吸衰竭,最初扩大到15.1厘米.
- 经过4周的治疗,他的病情有所改善,但仍然很大.
- 随访CT扫描显示持续的大病变 (13.0厘米在1年,9.2厘米在3年).
结论:
- 这一案例展示了一个罕见的ALA巨型病变的例子,在治疗后持续了多年.
- 严重的ALA与快速进展需要仔细监测和管理.
- 病变的长期持续表明需要进一步研究ALA治疗结果.
相关概念视频
Pulmonary Tuberculosis V
540
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
540
Pleural Effusion II: Symptoms and Management
655
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
655
Chronic Pancreatitis II: Collaborative Care
313
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
313
Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K

